I-Empagliflozin, umuthi oyinqaba, udonse ukunaka kochwepheshe bezokwelapha emhlabeni wonke. Lesi sidakamizwa esisha asisizi nje kuphela ukuphatha amazinga kashukela egazini kodwa futhi sibonisa imiphumela ethembisayo ekwelapheni izimo zenhliziyo. Isenzo sayo esiyingqayizivele siyenza ihluke emithini yendabuko yesifo sikashukela, enikeza ithemba ezigidini zeziguli ezinenkinga yalezi zinkinga zezempilo ezingamahlalakhona. Lesi sihloko sichaza kabanzi mayelana nomhlaba we-empagliflozin, ihlola ukusetshenziswa kwayo, imiphumela engemihle, nokuthi isebenza kanjani emzimbeni.
I-Empagliflozin umuthi osetshenziselwa ukuphatha isifo sikashukela sohlobo 2 kubantu abadala nasezinganeni ezineminyaka eyishumi nangaphezulu. Kungokwesigaba sezidakamizwa ze-sodium-glucose co-transporter 2 (SGLT2) inhibitor. I-FDA igunyaze i-empagliflozin ngo-2014. Odokotela bayinquma iyodwa noma ihlanganiswe neminye imithi ye-antidiabetic. I-Empagliflozin isebenza ngokwandisa ukuphuma kwe-glucose ngomchamo kanye nokwehlisa amazinga kashukela egazini. Le nqubo izimele ngaphandle kwe-insulin. Ngaphandle kokuphathwa kwesifo sikashukela, i-empagliflozin ibonise izinzuzo ekunciphiseni ubungozi benhliziyo kanye nokunciphisa ukuqhubeka kwesifo. isifo sezinso.
Ukusetshenziswa okuyinhloko kwamaphilisi e-empagliflozin ukuphatha uhlobo 2 lwesifo sikashukela i-mellitus (T2DM) ezigulini ezineminyaka eyishumi nangaphezulu. Basiza ukuthuthukisa ukulawulwa kwe-glycemic uma kuhlanganiswa nokudla nokuzivocavoca. Okunye ukusetshenziswa yilezi:
I-Empagliflozin, njengayo yonke imithi, ingadala imiphumela engemihle eminingi ye-empagliflozin, nakuba kungesibo bonke ababhekana nayo.
Imiphumela emibi ejwayelekile ye-empagliflozin ihlanganisa:
Lokhu kuvame ukuba ngcono njengoba umzimba ujwayela umuthi.
Imiphumela emibi kakhulu, nakuba ingavamile, ingenzeka. Lokhu kubandakanya:
I-Empagliflozin isebenza ngokuvimbela i-sodium-glucose co-transporter-2 (SGLT-2) kuma-proximal tubules ezinso. Lokhu kuvimbela kunciphisa ukumuncwa kabusha kwe-glucose futhi kukhulisa ukuphuma kwe-glucose kumchamo, kwehlisa amazinga kashukela egazini ngaphandle kwesenzo se-insulin. I-Empagliflozin ngokuvamile yehlisa i-HbA1c cishe ngo-0.7%. Umuthi uthathwa ngomlomo, ngesilinganiso esinconyiwe samamiligremu ayi-10 kanye ngosuku ekuseni, ngokudla noma ngaphandle kokudla. Uma kubekezelelwa, umthamo ungakhuphuka ube ngu-25 mg. Akukho ukulungiswa komthamo okudingekile ezigulini ezine-eGFR ≥ 45 mL/min/1.73 m2. Kodwa-ke, i-empagliflozin ayinconywa kubantu abane-eGFR> 30 mL/min/1.73 m2 ngaphandle kwezinto eziyingozi zenhliziyo.
I-Empagliflozin ingathathwa kanye neminye imithi, ikakhulukazi leyo esetshenziselwa ukuphatha isifo sikashukela nempilo yenhliziyo. Odokotela ngokuvamile banquma lo muthi njengendlela yokwelapha eyinhlanganisela ne-metformin noma i-linagliptin. Ezigulini ezinesifo sikashukela sohlobo 2 kanye nesifo senhliziyo esimisiwe, i-empagliflozin ingasetshenziswa kanye nemithi yokunakekela ejwayelekile. Kubalulekile ukuqaphela ukuthi i-empagliflozin inomthelela ekusebenzeni kwezinso, ngakho ukuqapha kubalulekile lapho kuhlanganiswa nezinye izidakamizwa. Iziguli kufanele njalo zazise udokotela wazo mayelana nemithi yazo eqhubekayo ukuze kuqinisekiswe ukwelashwa okuphephile nokusebenzayo.
I-Empagliflozin ingasebenzisana nemithi eminingi, njenge:
I-Empagliflozin ivamise ukuthathwa kanye ngosuku ekuseni, ngokudla noma ngaphandle kokudla. Umthamo wokuqala onconyiwe ungamamiligremu ayishumi, angakhuphukela ku-25 mg uma kubekezelelwa kahle. Kubalulekile ukugcina i-hydration efanele ngenkathi uthatha i-empagliflozin. Odokotela bangalungisa umthamo ngokusekelwe ezicini zesiguli ngasinye, njengokusebenza kwezinso. Ukuqapha njalo kubalulekile ukuze kuqinisekiswe ukusebenza kahle nokuphepha komuthi.
I-Empagliflozin ifakazele ukuthi ishintsha kakhulu ekulawuleni uhlobo 2 lwesifo sikashukela kanye nezimo zenhliziyo. Ngokwandisa ukuphuma kwe-glucose ngomchamo, indlela yayo eyingqayizivele yokusebenza inikeza indlela entsha yokulawula ushukela wegazi. Lo muthi awusizi nje ngesifo sikashukela; kuphinde kube nomthelela omuhle empilweni yenhliziyo nokusebenza kwezinso. Lezi zinzuzo zenza kube inketho ebalulekile ezigulini eziningi, ikakhulukazi lezo ezibhekene nezinkinga eziningi zempilo.
Izimpendulo: Inkomba eyinhloko ye-empagliflozin ukwelapha uhlobo 2 lwesifo sikashukela i-mellitus (T2DM) kubantu abadala nasezinganeni ezineminyaka eyishumi nangaphezulu. Kuyasiza ukuthuthukisa amazinga kashukela egazini uma kuhlangene nokudla nokuzivocavoca. Ukwengeza, kunciphisa ingozi yokufa kwenhliziyo nemithambo yegazi kubantu abadala abanesifo sikashukela sohlobo 2 kanye nesifo senhliziyo.
Izimpendulo: Odokotela ngokuvamile banikeza i-empagliflozin kubantu abane thayipha 2 sikashukela, ikakhulukazi labo abasengozini yezenzakalo zenhliziyo nemithambo yegazi. Kuyasiza futhi kubantu abadala abanenkinga yenhliziyo ukunciphisa ingozi yokulaliswa esibhedlela nokufa ngenxa yesifo senhliziyo. Abantu abanesifo sezinso bangazuza ku-empagliflozin ukuze babambezele ukukhula kwesifo.
Impendulo: I-Empagliflozin ivamise ukuthathwa kanye ngosuku, kungaba ekuseni noma kusihlwa. Ukusetshenziswa njalo njengoba kunqunywe udokotela akubhekwa njengokuyingozi.
Impendulo: I-Empagliflozin ibonise iphrofayili yokuphepha evumayo ezivivinyweni zomtholampilo. Kodwa-ke, njengayo yonke imithi, ingabangela imiphumela emibi. Ezivamile zihlanganisa izifo zomgudu womchamo kanye nezitho zangasese.
Izimpendulo: I-Empagliflozin ayinconywa kubantu abanesifo sikashukela sohlobo loku-1, i-ketoacidosis yesifo sikashukela, ukukhubazeka okukhulu kwezinso, isifo sezinso esisekupheleni, noma labo abaku-dialysis. Abesifazane abakhulelwe, ikakhulukazi ku-trimester yesibili neyesithathu, kufanele bagweme i-empagliflozin.
Impendulo: I-Empagliflozin ibonise izinzuzo ekubambezeleni ukuqhubeka kwesifo sezinso esingamahlalakhona. Kodwa-ke, odokotela abayitusi ezigulini ezinokukhubazeka okukhulu kwezinso (i-eGFR ngaphansi kuka-30 mL/min/1.73 m2
Impendulo: I-Empagliflozin ingaphuzwa nganoma yisiphi isikhathi sosuku, kuhlanganisa nasebusuku. Okubalulekile wukuyithatha ngesikhathi esifanayo usuku nosuku ukuze ugcine amazinga egazi aqinile emuthi.
Izimpendulo: Isikhathi esingcono kakhulu sokuthatha i-empagliflozin isikhathi esisebenza ngokungaguquki nohlelo lwakho lwansuku zonke. Ingathathwa ngokudla noma ngaphandle kokudla.
Izimpendulo: I-Empagliflozin kufanele imiswe ezinsukwini ezi-3-4 ngaphambi kokuhlinzwa okuhleliwe ukuze kuncishiswe ubungozi be-ketoacidosis yangemva kokuhlinzwa. Ukwengeza, udokotela angase atuse ukuyekwa uma imiphumela emibi kakhulu ivela noma imithi ingasebenzi. Hlala uthintana nodokotela wakho kuqala ngaphambi kokumisa i-empagliflozin.